Journals / The European Research Journal / 2023 / Cilt: 9 - Sayı: 2

Pulmonary and cardiac involvement in patients with rheumatoid arthritis and ankylosing spondylitis

Pages
291–300
Publication Date
2023-03-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In RA, no significant difference was determined between PFT and DAS-28 results, as a result, the disease activity will not directly indicate pulmonary involvement.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Our aim is to study the disease activity status, laboratory data and to determine the frequency of cardiac and pulmonary findings in patients with Rheumatoid arthritis (RA) and ankylosing spondylitis (AS).
📊
Key Findings & Data:Methods: Forty-five AS patients and 78 RA patients took part in the study.
💡
Conclusion & Impact:In RA, no significant difference was determined between PFT and DAS-28 results, as a result, the disease activity will not directly indicate pulmonary involvement.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Rheumatoid arthritis · ankylosing spondylitis · high-resolution computed tomography

Abstract

Objectives: Our aim is to study the disease activity status, laboratory data and to determine the frequency of cardiac and pulmonary findings in patients with Rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Methods: Forty-five AS patients and 78 RA patients took part in the study. The C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), albumin, creatinine, ALT, leukocyte, neutrophil ratio, hemoglobin, platelet, rheumatoid factor (RF), and anti-cyclic citrullinated peptide (anti-CCP) levels were measured. In addition, the patients' thoracic computed tomography, high-resolution computed tomography (HRCT), echocardiography (ECHO), and pulmonary function test (PFT) results were evaluated. Disease activity was assessed with the Disease Activity Score-28 (DAS-28) in RA patients, whereas the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) was used in patients with AS. Results: The relationship between the anti-CCP value and gender was significant in RA patients. Significant differences were present between gender and hemoglobin value in RA and AS patients, whereas no significant differences were determined between CRP, ESR, platelet, and DAS-28 values. There was a significant difference between RF and ESR values in RA patients, whereas no significant difference was present between CRP, leukocyte, DAS-28, hemoglobin, and platelet values. Pulmonary involvement was determined in 35.7% of RA patients and 4.2% of AS patients. The difference between these was statistically significant. Conclusions: The most common pulmonary involvement is millimetric nonspecific nodule and the most common lesion among ECHO findings was left ventricular diastolic dysfunction in RA and AS patients. In RA, no significant difference was determined between PFT and DAS-28 results, as a result, the disease activity will not directly indicate pulmonary involvement.

🔖

Cite This Article

TEKELİ, A. H. (2023). Pulmonary and cardiac involvement in patients with rheumatoid arthritis and ankylosing spondylitis. The European Research Journal, Cilt: 9 - Sayı: 2, 291–300. https://ajindex.com/articles/888787

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Çalgüneri M. Romatoid Artrit. In: Yasavul Ü, Ed., Hacettepe İç Hastalıkları Kitabı Ankara: Prestij Basımevi; 2003: pp. 1477-95
  2. Lipsky PE. Rheumatoid Arthritis. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL editors. Harrison's Principles of Internal Medicine. New York: McGraw-Hill; 2005. pp. 1968-77
  3. Hellmann DB, Stone JH. Rheumatoid Arthritis. In: Tierney LM, McPhee SJ, Papadakis MA editors. Current Medical Diagnosis & Treatment. New York: McGraw-Hill; 2005; pp. 801-7
  4. Fuchs HA, Sergent SJ. Rheumatoid arthritis the clinical picture. In: Koopman WJ (ed). Arthritis and Allied conditions, 13th ed. Pennsylvania: Williams and Wilkins, 1997: pp. 1041-70
  5. Firestein GS. Etiology and pathogenesis of rheumatoid arthritis. In: Ruddy S, Haris ED, Sledge CB (eds). Kelley's Textbook of Rheumatology, sixth ed. Philadelphia: WB Saunders, 2001: pp. 921-1000
  6. Harris ED. Clinical features of rheumatoid arhritis. In: Ruddy S, Harris ED, Sledge CB (eds). Texbook of Rheumatology, 6th ed. Philadelphia: WB Saunders, 2001: pp. 967-1000
  7. Halla JT, Schrohenloher RE, Koopman WJ. Local Ġmmüno responses in certain extraarticular manifestations of rheumatoid arthritis. Ann Rheum Dis 1992;51:698-701
  8. Gray S. Romatoid Artrit. In Edward D. Harris JR, Ralph C, Clement B (ed)s. Kelley’s Textbook of Rheumatology. çeviri: Arasıl T. Kelley Romatoloji 7. baskı. Ankara: Güneş Kitabevi, 2006:996-1078
  9. Hamuryudan V. Romatoid artrit. Sempozyum 2007;55:69-86
  10. Tanoue LT. Pulmonary manifestations of rheumatoid arthritis. Clinic Chest Med 1998;19:667-85
  11. Holmqvist ME, Neovius M, Eriksson J, Mantel A, Wallberg-Jonsson S, Jacobsson LTH, et al. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. JAMA 2012; 308:1350-6
  12. Özgöçmen S. Tanı ve Sınıflama Kriterleri. Ankilozan spondilit ve spondiloartropatiler (çeviri), çeviri ed: Özgöçmen S. Birinci baskı. Veri medikal yayıncılık, İstanbul, 2008: pp. 24-6
  13. Onel D. Romatizmal Hastalıklar. Tayf Ofset, İstanbul, 1994: pp. 326-7
  14. Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosing spondylitis: an overview. Ann Rheum Dis 2002; 61 Suppl 3:iii8-18
  15. Niccoli L, Nannini C, Cassarà E, Kaloudi O, Cantini F. Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFα drugs and therapy-induced changes. Int J Rheum Dis 2012;15:56-61
  16. Slobodin G, Naschitz JE, Zuckerman E, Zisman D,